全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2017 

替加环素治疗重症患者呼吸机相关性肺炎
Tigecycline in treating ventilator-associated pneumonia in critically ill patients

DOI: 10.6040/j.issn.1671-7554.0.2016.692

Keywords: 替加环素,多重耐药,鲍曼不动杆菌,危重症,呼吸机相关性肺炎,
Tigecycline
,Critical Illness,Drug Resistance, Multiple,Acinetobacter baumannii,Pneumonia, Ventilator-Associated

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]  谭建龙, 张卫东, 柳威, 等. 替加环素治疗多或泛耐药鲍曼不动杆菌肺炎的疗效观察[J]. 中国呼吸与危重监护杂志, 2013, 12(6): 581-585. TAN Jianlong, ZHANG Weidong, LIU Wei, et al. Clinical experience with tigecycline in the treatment of multi/extensively drug-resistant acinetobacter baumannii pneumonia[J]. Chinese Journal of Respiratory and Critical Care Medicine, 2013, 12(6): 581-585.
[2]  Montravers P, Dupont H, Bedos JP, et al. Tigecycline use in critically ill patients: a multicentre prospective observational study in the intensive care setting[J]. Intensive Care Med, 2014, 40(7): 988-997.
[3]  Cai Y, Bai N, Liu X, et al. Tigecycline: Alone or in combination?[J]. Infect Dis(Lond), 2016, 48(7): 491-502.
[4]  Bhavnani SM, Rubino CM, Hammel JP. et al. Pharmacological and patient-specific response determinants in patients with hospital-acquired pneumonia treated with tigecycline[J]. Antimicrob Agents Chemother, 2012, 56(2): 1065-1072.
[5]  Eckmann C, Heizmann WR, Leitner E, et al. Prospective, non-interventional, multi-centre trial of tigecycline in the treatment of severely ill patients with complicated infections: new insights into clinical results and treatment practice[J]. Chemotherapy, 2011, 57(4): 275-284.
[6]  Ellis-Grosse EJ, Babinchak T, Dartois N, et al. Tigecycline 300 cSSSI study group; Tigecycline 305 cSSSI study group. The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam[J]. Clin Infect Dis, 2005, 41(5): 341-353.
[7]  Tanaseanu C, Bergallo C, Teglia O, et al. Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia[J]. Diagn Microbiol Infect Dis, 2008, 61(3): 329-338.
[8]  Shin JA, Chang YS, Kim HJ, et al. Clinical outcomes of tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii infection[J]. Yonsei Med, 2012, 53(5): 974-984.
[9]  管向东, 刘紫锰. 2013《呼吸机相关性肺炎诊断、预防和治疗指南》—目标性治疗的解读[J]. 中华医学杂志, 2014, 94(5): 333-334.
[10]  Cai Y, Wang R, Liang B, et al. Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease[J]. Antimicrob Agents Chemother, 2011, 55(3): 1162-1172.
[11]  中华医学会重症医学分会. 呼吸机相关性肺炎诊断、预防和治疗指南(2013)[J]. 中华内科杂志, 2013, 52(6): 524-543.
[12]  《抗菌药物临床试验技术指导原则》写作组. 抗菌药物临床试验技术指导原则[J]. 中国临床药理学杂志, 2014(9): 844-856.
[13]  Stein GE, Babinchak T. Tigecycline: an update[J]. Diagn Microbiol Infect Dis, 2013, 75(4): 331-336.
[14]  朱任媛, 张小江, 杨启文, 等. 卫生部全国细菌耐药监测网2011年ICU来源细菌耐药监测[J]. 中国临床药理学杂志, 2012, 28(12): 905-909. ZHU Renyuan, ZHANG Xiaojiang, YANG Qiwen, et al. Ministry of health national antimicrobial resistance investigation net annual report of 2011: surveillance of antimicrobial resistance in bacteria from intensive care units[J]. The Chinese Journal of Clinical Pharmacology, 2012, 28(12): 905-909.
[15]  Wu Yuhong, Shao Zonghong. High-dosage tigecycline for Stenotrophomonas maltophilia bacteremia[J]. Chin Med J(Engl), 2014, 127(17): 3199.
[16]  Moya Cordero P, Ruiz-Aragón J, Molina Linde JM, et al. Evaluation of the efficacy and safety of tigecycline for treatment of respiratory tract infections. Systematic review of literature[J]. Revista Chilena De Infectologia, 2013, 30(6): 591-597.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133